An Overview of Fanconi Anemia: A Genetic Disorder

Year : 2024 | Volume : 02 | Issue : 02 | Page : 19 25
    By

    Hemin Johnson,

  1. Lecturer, Department of Community Health Nursing, Jubilee Mission College of Nursing, Karnataka, India

Abstract

Fanconi Anemia (FA) is a rare genetic disorder caused by DNA repair defects due to pathogenic variants in one of 21 genes. It is the primary cause of inherited bone marrow failure, marked by pancytopenia. Clinically, Fanconi Anemia (FA) is associated with congenital malformations in multiple systems, resulting in progressive bone marrow failure and heightened cancer risk, especially in the urogenital region and the head and neck. There are approximately 20 FA-related genes, but not all are impacted by mutations. These genes play a critical role in protecting against DNA damage accumulated over a lifetime. Fanconi anemia affects about 1 in 136,000 newborns, with an incidence of 1 in 100,000 to 250,000 births Mutations in three particular genes—FANCA, FANCC, and FANCG—are responsible for 80% to 90% of cases of Fanconi Anemia (FA). Clinical symptoms typically manifest in early childhood or young adulthood, with signs at birth including growth deficiencies, skeletal anomalies, small head or eyes, and abnormal skin pigmentation. In young children, symptoms can include unexplained fatigue, frequent infections, recurrent nosebleeds, easy bruising, blood in stool or urine, and other haematological issues. Several disorders linked to Fanconi Anaemia (FA) include Diamond Blackfan Anemia (DBA), Paroxysmal Nocturnal Hemoglobinuria (PNH), Schwachman-Diamond Syndrome (SDS), and Bloom Syndrome (BS). Diagnostic assessments involve array comparative genomic hybridization (array-CGH), cytogenetic testing, and molecular testing. Treatment options include oral androgen administration, recommendations for hematopoietic stem cell transplantation (HSCT), vitamin D supplementation, various therapies, hearing aids, blood transfusions, and genetic counselling.

Keywords: Fanconi anaemia (FA), FANCA, FANCC, FANCG, schwachman – diamond syndrome (SDS), and bloom syndrome (BS), Array comparative genomic hybridization (array-CGH)

[This article belongs to International Journal of Oncological Nursing and Practices ]

How to cite this article:
Hemin Johnson. An Overview of Fanconi Anemia: A Genetic Disorder. International Journal of Oncological Nursing and Practices. 2024; 02(02):19-25.
How to cite this URL:
Hemin Johnson. An Overview of Fanconi Anemia: A Genetic Disorder. International Journal of Oncological Nursing and Practices. 2024; 02(02):19-25. Available from: https://journals.stmjournals.com/ijonnp/article=2024/view=168753


References

  1. Alter BP. Fanconi Anemia. NORD Guide to Rare Disorders. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:366.
  2. Buyse ML. Editor-in-Chief. Birth Defects Encyclopedia. Dover, MA: Blackwell Scientific Publications. Center for Birth Defects Information Services, Inc.; 1990:1359-61,1784.
  3. Mehta PA, Ebens C. Fanconi Anemia. 2002 Feb 14 [Updated 2021 Jun 3]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1401/ .
  4. Frohnmayer D, Frohnmayer L, Guinan E, Kennedy T, Larsen K, Editors. Fanconi Anemia: Guidelines for Diagnosis and Management, Fourth Edition, 2014. Fanconi Anemia Research Fund, Inc. Available at: https://www.fanconi.org/images/uploads/other/Guidelines_4th_Edition.pdf
  5. Bhandari J, Thada PK, Killeen RB, et al. Fanconi Anemia. [Updated 2024 Jun 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559133/
  6. National Institutes of Health. Fanconi anemia. Last Update November 1, 2011. Available online at: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fanconi-anemia#:~:text=A%20rare%20inherited%20disorder%20in,bleed%20easily%2C%20and%20extreme%20tiredness.
  7. National Organization for Rare Diseases. Fanconi Anemia. Available online at: https://rarediseases.org/rare-diseases/fanconi-anemia/ Accessed 4/15/2022.
  8. Boston’s Children Hospital. Fanconi Anaemia. Available online at: https://www.childrenshospital.org/conditions/fanconi-anemia) Accessed 22/04/2024.
  9. Rayi A, Hozayen S. Chromosome Instability Syndromes. [Updated 2022 Sep 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537198/ .
  10. Keefe P, Bokhari SRA. Fanconi Syndrome. [Updated 2023 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534872/
  11. Dalle JH. HSCT for Fanconi anemia in children: factors that influence early and late results. Bone Marrow Transplant. 2008 Oct;42 Suppl 2:S51-3. doi: 10.1038/bmt.2008.284. PMID: 18978745.
  12. Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, Harris RE, Marsh JC, Robinson AJ, Zhang MJ, Eapen M, Wagner JE. HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biol Blood Marrow Transplant. 2008 Oct;14(10):1141-1147. doi: 10.1016/j.bbmt.2008.06.020. PMID: 18804044; PMCID: PMC2581414.
  13. Mitchell R, Wagner JE, Hirsch B, DeFor TE, Zierhut H, MacMillan ML. Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia. Br J Haematol. 2014 Feb;164(3):384-95. doi: 10.1111/bjh.12634. Epub 2013 Oct 30. PMID: 24172081; PMCID: PMC4060801.
  14. Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010 May;24(3):101-22. doi: 10.1016/j.blre.2010.03.002. Epub 2010 Apr 24. Erratum in: Blood Rev. 2010 Jul-Sep;24(4-5):201. PMID: 20417588; PMCID: PMC3733544.
  15. Belo H, Silva G, Cardoso BA, Porto B, Minguillon J, Barbot J, Coutinho J, Casado JA, Benedito M, Saturnino H, Costa E, Bueren JA, Surralles J, Almeida A. Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential. PLoS One. 2015 Oct 14;10(10):e0139740. doi: 10.1371/journal.pone.0139740. PMID: 26466379; PMCID: PMC4605638.
  16. de Winter JP, Joenje H. The genetic and molecular basis of Fanconi anemia. Mutat Res. 2009 Jul 31;668(1-2):11-9. doi: 10.1016/j.mrfmmm.2008.11.004. Epub 2008 Nov 14. PMID: 19061902.
  17. Deakyne JS, Mazin AV. Fanconi anemia: at the crossroads of DNA repair. Biochemistry (Mosc). 2011 Jan;76(1):36-48. doi: 10.1134/s0006297911010068. PMID: 21568838.
  18. Green AM, Kupfer GM. Fanconi anemia. Hematol Oncol Clin North Am. 2009 Apr;23(2):193-214. doi: 10.1016/j.hoc.2009.01.008. PMID: 19327579; PMCID: PMC5912671.
Regular Issue Subscription Review Article
Volume 02
Issue 02
Received 28/08/2024
Accepted 27/10/2024
Published 05/11/2024
646

Login


My IP

PlumX Metrics